Abstract:Zhengyu Fang, 1, &ast Peihong Lin, 1, &ast Rui Gao, 1, &ast Wenjing Yang, 1 Aizhen Zhou, 2 Wenying Yu 1, 3 1 School of Pharmacy, Hangzhou Medical College, Hangzhou, 310013, People's Republic of China; 2 Department of Traditional Chinese Medicine, Zhejiang Pharmaceutical University, Ningbo, 315500, People's Republic of China; 3 Key Laboratory of Neuropsychiatric Drug Research of Zhejiang Province, Hangzhou Medical College, Hangzhou, 310013, People's Republic of China &astThese authors contributed equally to this work Correspondence: Aizhen Zhou; Wenying Yu, Tel +86 571 88215623, Email ; Background: Tetrandrine (Tet), a bisbenzylisoquinoline alkaloid, is a potential candidate for cancer chemotherapy. However, Tet has poor aqueous solubility and a short half-life, which limits its bioavailability and efficacy. Liposomes have been widely utilized to enhance the bioavailability and efficacy of drugs. Methods: In this study, Tet-loaded stealth liposomes (S-LPs@Tet) were prepared by ethanol injection method. Furthermore, physicochemical characterisation, biopharmaceutical behaviour, therapeutic efficacy, and biocompatibility of S-LPs@Tet were assessed. Results: The prepared S-LPs@Tet had an average particle size of 65.57 ± 1.60 nm, a surface charge of − 0.61 ± 0.10 mV, and an encapsulation efficiency of 87.20% ± 1.30%. The S-LPs@Tet released Tet in a sustained manner, and the results demonstrated that the formulation remained stable for one month. More importantly, S-LPs significantly enhanced the inhibitory ability of Tet on the proliferation and migration of lung cancer cells, and enabled Tet to escape phagocytosis by immune cells. Furthermore, in vivo studies confirmed the potential for long-circulation and potent tumor-suppressive effects of S-LPs@Tet. Moreover, ex vivo and in vivo safety experiments demonstrated that the carrier material S-LPs exhibited superior biocompatibility. Conclusion: Our research suggested that S-LPs@Tet has potential applications in lung cancer treatment. Keywords: tetrandrine, S-LPs, lung cancer, immune escape, in vivo imaging Tetrandrine (Tet) is a natural product belonging to the bis-benzylisoquinoline alkaloid family (Figure 1) that was originally isolated and purified from the roots of the traditional Chinese medicinal herb Stephania tetrandra S. Moore . 1 Multiple studies have shown that Tet has a wide range of diverse pharmacological effects. The antitumor effect of Tet is a widely investigated pharmacological activity, primarily achieved through direct inhibition of cell proliferation, induction of apoptosis and autophagy in cancer cells, inhibition of migration and invasion of tumor cells, and reversal of multidrug resistance in tumor cells, among other mechanisms. 2–4 Figure 1 ( A ) The Stephania tetrandra S. Moore and ( B ) molecular structure of Tet. Tet tablets and injections are currently available on the market. However, due to the poor aqueous solubility of Tet, its tablets are not easily absorbed by the human body and have low bioavailability. 5 Additionally, Tet Injection has the side effect of localized irritation and pain during clinical use. 6,7 Free Tet has a short half-life of 7 hours in plasma 8 and is easily cleared, resulting in poor efficacy. 9,10 Therefore, there is an urgent need to develop a suitable drug delivery system to enhance the bioavailability and therapeutic efficacy of Tet. In recent years, nanotechnology has shown promising applications in tumor treatment. Among these, liposomes (LPs) are the most widely used and stable biological nanoparticles in antitumor research due to their biocompatibility and high utility. Several LPs have been clinically approved as nanodrugs, such as Doxil ® , Dauno Xome ® , and Depocyt ® . LPs have garnered significant attention as traditional drug delivery vehicles due to their relatively simple composition, capacity to effectively encapsulate a wide range of hydrophilic and hydrophobic drugs, and high clinical translational value. 7 However, the main drawback of conventional LPs is that they are easily recognized by the reticuloendothelial system, leading to a short half-life and poor stability. Poly (ethylene glycol)–distearoylphosphatidylethanolamine (DSPE-PEG) is an amphiphilic polymer with a hydrophobic core (DSPE) and a hydrophilic shell (PEG). 11 Therefore, incorporating DSPE-PEG into conventional LPs can not only enhance the solubility of drugs in water, 12 but also facilitate the escape of L -Abstract Truncated-

Study on the Distribution of Lung Targeted-Tetrandrine Sustained-Release Albumin Microcapsules in Vivo

Alternation of Organ-Specific Exposure in LPS-Induced Pneumonia Mice after the Inhalation of Tetrandrine Is Governed by Metabolizing Enzyme Suppression and Lysosomal Trapping

Assessment of the Effect of Tetrandrine-Loaded Solid Lipid Nanoparticles on Plasma Metabolite Profile Using Metabolomics

Tissue Distribution of 10-Hydroxycamptothecin Microcapsules in Mice

Preparation of Tetrandrine Nanocrystals by Microfluidic Method and Its In Vitro and In Vivo Evaluation

Tissue distribution of tetramethylpyrazine intralipid in mice

Quantification of paclitaxel in rat plasma by LC-MS/MS and pharmacokinetics of paclitaxel thermosensi-tive liposomes in rats

Tissue Distribution of Paclitaxel Liposome in Rats and Tumor Bearing Nude Mice

Distribution of Rifampicin Ethylcellulose Microcapsules in Various Tissues of Mice

Enhanced Antitumor Efficacy of Novel Biomimetic Platelet Membrane-Coated Tetrandrine Nanoparticles in Nonsmall Cell Lung Cancer

Tissue distribution and targeting evaluation of TMP after oral administration of TMP-loaded microemulsion to mice

Study on preparation, characterization and multidrug resistance reversal of red blood cell membrane-camouflaged tetrandrine-loaded PLGA nanoparticles

Study on tumor active targeting with Transferrin-PEG-PAMAM dendrimer-CPT conjugate

Inhalation of tetrandrine liposomes for the treatment of bleomycin induced idiopathic pulmonary fibrosis

Preparation, Characterization, and Anti-Lung Cancer Activity of Tetrandrine-Loaded Stealth Liposomes

Method Development and Application for Multi-Component Quantification in Rats after Oral Administration of Longxuetongluo Capsule by UHPLC–MS/MS

Acute and Sub-Chronic Toxicity of Tetrandrine in Intravenously Exposed Female BALB/c Mice

Study on in Vivo Distribution of Liver-Targeting Nanopaticles Encapsulating Thymidine Kinase Gene (TK Gene) in Mice

Preparation and Characterisation of Tetrandrine Nanosuspensions Andin Vitroestimate Antitumour Activity on A549 Lung Cancer Cell Line

Advances in nano‐preparations for improving tetrandrine solubility and bioavailability

Proteomic Analysis of Anti-Tumor Effects by Tetrandrine Treatment in Hepg2 Cells